Botulinum Toxin (BOTOX) for Cerebral Palsy

Completed · Phase 2

Conditions studied: Cerebral Palsy, Muscle Spasticity

In brief

This study examines botulinum toxin (BOTOX, or BTX) for the treatment of muscle twitches and spasticity associated with cerebral palsy in children. Botulinum toxin is a naturally occurring bacterial toxin (botulinum toxin) that inactivates certain parts of muscles.

Key facts

Study ID

NCT00060957

Run by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

People needed

40

Starts

1997-07-01

Last updated by the study team

2016-09-26

Who can join

Age: 3 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Spastic diplegic cerebral palsy
• Community or independent ambulators
• Expressive communication skills at age 3 or above
• Stable social environment
• Reasonable proximity to the medical center
• Physical therapy at least once per week
• No other serious health problems that would interfere with the study

You may not qualify if…

• Other forms of cerebral palsy
• Previous treatment with botulinum toxin
• Musculoskeletal contractures greater than 15 degrees
• Unstable social environment

Where it is running

• Children's Hospital and Regional Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.